You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

teplizumab

Showing 1 - 4 of 4
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 1 Diabetes Trial in Atlanta (Teplizumab)

Terminated
  • Type 1 Diabetes Mellitus
  • Teplizumab
  • Atlanta, Georgia
    Atlanta Diabetes Associates
Feb 4, 2022

Diabetes, Type 1 Trial in Belgium, United States (AG019 - Low Dose, Teplizumab, Placebo-AG019)

Completed
  • Diabetes Mellitus, Type 1
  • AG019 - Low Dose
  • +5 more
  • Birmingham, Alabama
  • +17 more
Nov 9, 2021

Autoantibody Positive, Non-diabetic Relatives at Risk for Type 1 Diabetes, High Risk Trial in Canada, Germany, United States

Completed
Has Results
  • Autoantibody Positive
  • +3 more
  • Teplizumab
  • Placebo infusion
  • San Francisco, California
  • +18 more
Jul 21, 2020

Type 1 Diabetes Trial in Worldwide (Teplizumab, Placebo)

Completed
  • Type 1 Diabetes Mellitus
  • Teplizumab
  • Placebo
  • Birmingham, Alabama
  • +114 more
Feb 4, 2022